Kathryn (Katie) Chandra is Head of State Policy for Genentech's US Policy & Evidence Team. Katie leads the state policy team in proactive and reactive strategy development and engagement on state policies affecting Genentech's business and patient access to medications. Prior to joining Genentech in 2012, Katie led state policy and advocacy efforts at the American Academy of Dermatology Association and served in several positions at the Washington, DC-based non-profit organization, Women In Government. Katie holds a Bachelor's Degree in Political Communications and a Master's Degree in Political Management from The George Washington University. Recent speaking engagements include: Chandra, Kathryn G. “Prescription Drug Affordability Boards (PDABs): Are There Opportunities for Robust and Transparent Engagement?” ISPOR 2025. Montreal, Canada, 16 May 2025. Chandra, Kathryn G. “State Prescription Drug Affordability Boards.” Maryland Tech Council Annapolis Day. Annapolis, Maryland, 15 Jan 2025. Chandra, Kathryn G. “State Policy Trends: Prescription Drug Affordability Boards.” Medicaid and Government Pricing Congress. Washington, DC, 16 May 2023.